Similar to obesity, the prevalence of MS—or comparable cardiovascular risk profiles—tends to increase with age among ALL survivors, is more common in females than males, and has been associated with prior exposure to cranial radiotherapy (CRT) and/or growth hormone (GH) abnormalities [40] (Table 2). Here, GH1 is linked to Obesity.